IGF1 and sarcopenia: It has been administered on human cell cultures, and it has been concluded that the MGF-24aa-E peptide alone has a marked ability to enhance satellite cell activation, proliferation, and fusion for muscle repair and maintenance and could provide a new strategy to combat age-related sarcopenia without the oncogenic side effects observed for IGF1 [118].